| JHJCX | VFFSX | JHJCX / VFFSX | |
| Total Expense Ratio | 1.87 | 0.01 | 18,700% |
| Annual Report Gross Expense Ratio | 2.08 | 0.01 | 20,800% |
| Fund Existence | 9 years | 9 years | - |
| Gain YTD | 6.293 | 12.736 | 49% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 118M | 1.46T | 0% |
| Annual Yield % from dividends | 0.00 | 1.13 | - |
| Returns for 1 year | -5.51 | 11.90 | -46% |
| Returns for 3 years | 31.03 | 67.07 | 46% |
| Returns for 5 years | 39.06 | 86.25 | 45% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LICPX | 18.03 | N/A | N/A |
| Lord Abbett International Equity P | |||
| UOPIX | 137.35 | N/A | N/A |
| ProFunds UltraNASDAQ-100 Inv | |||
| CBGAX | 15.01 | N/A | N/A |
| ClearBridge Global Infrastructure Inc C | |||
| MSVEX | 6.28 | N/A | N/A |
| Morgan Stanley Vitality Portfolio A | |||
| JFNAX | 79.65 | -0.17 | -0.21% |
| Janus Henderson Global Life Sciences A | |||